Related Experiment Video
Updated: Mar 9, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Parental Refusal of Vitamin K and Neonatal Preventive Services: A Need for Surveillance
Lauren H Marcewicz1,2,3, Joshua Clayton4,5, Matthew Maenner4,6
1Centers for Disease Control and Prevention, Epidemic Intelligence Service, Atlanta, GA, USA. lauren.marcewicz@gmail.com.
Insights
Parental refusal of injectable vitamin K for newborns is higher at birthing centers than hospitals. Common reasons include belief in its necessity and preference for natural birth processes.
Area of Science:
- Pediatrics
- Public Health
- Neonatal Care
Background:
- Vitamin K deficiency bleeding (VKDB) is a preventable infant coagulopathy.
- Injectable vitamin K at birth is the standard prophylaxis.
- Parental refusal of this intervention prompted investigation.
Purpose of the Study:
- To investigate parental refusal rates of injectable vitamin K in Tennessee.
- To identify reasons for refusal and associated factors.
- To compare refusal rates between hospital births and birthing centers.
Main Methods:
- Chart reviews at Nashville-area hospitals (2011-2013) and Tennessee birthing centers (2013).
- Identification of infants whose parents refused vitamin K prophylaxis.
- Surveys administered to parents to determine reasons for refusal.
Main Results:
- In 2013, 3.0% of hospital infants and 31% of birthing center infants did not receive vitamin K due to refusal.
- Primary refusal reasons: belief in necessity (53%) and natural birth preference (36%).
- 66% of families refusing vitamin K also refused other newborn preventive services.
Conclusions:
- Injectable vitamin K refusal is significantly higher in birthing centers compared to hospitals.
- Refusal is associated with a broader pattern of rejecting other preventive newborn care.
- Enhanced surveillance and targeted strategies are needed to address vitamin K refusal.
Abstract:
Objectives Vitamin K deficiency bleeding (VKDB) in infants is a coagulopathy preventable with a single dose of injectable vitamin K at birth. The Tennessee Department of Health (TDH) and Centers for Disease Control and Prevention (CDC) investigated vitamin K refusal among parents in 2013 after learning of four cases of VKDB associated with prophylaxis refusal. Methods Chart reviews were conducted at Nashville-area hospitals for 2011-2013 and Tennessee birthing centers for 2013 to identify parents who had refused injectable vitamin K for their infants. Contact information was obtained for parents, and they were surveyed regarding their reasons for refusing. Results At hospitals, 3.0% of infants did not receive injectable vitamin K due to parental refusal in 2013, a frequency higher than in 2011 and 2012. This percentage was much higher at birthing centers, where 31% of infants did not receive injectable vitamin K. The most common responses for refusal were a belief that the injection was unnecessary (53%) and a desire for a natural birthing process (36%). Refusal of other preventive services was common, with 66% of families refusing vitamin K, newborn eye care with erythromycin, and the neonatal dose of hepatitis B vaccine. Conclusions for Practice Refusal of injectable vitamin K was more common among families choosing to give birth at birthing centers than at hospitals, and was related to refusal of other preventive services in our study. Surveillance of vitamin K refusal rates could assist in further understanding this occurrence and tailoring effective strategies for mitigation.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity

